284 related articles for article (PubMed ID: 22583011)
1. miR-17-5p as a novel prognostic marker for hepatocellular carcinoma.
Chen L; Jiang M; Yuan W; Tang H
J Invest Surg; 2012 Jun; 25(3):156-61. PubMed ID: 22583011
[TBL] [Abstract][Full Text] [Related]
2. Hepatocellular carcinoma associated microRNA expression signature: integrated bioinformatics analysis, experimental validation and clinical significance.
Shi KQ; Lin Z; Chen XJ; Song M; Wang YQ; Cai YJ; Yang NB; Zheng MH; Dong JZ; Zhang L; Chen YP
Oncotarget; 2015 Sep; 6(28):25093-108. PubMed ID: 26231037
[TBL] [Abstract][Full Text] [Related]
3. High expression of serum miR-17-5p associated with poor prognosis in patients with hepatocellular carcinoma.
Zheng J; Dong P; Gao S; Wang N; Yu F
Hepatogastroenterology; 2013 May; 60(123):549-52. PubMed ID: 23108086
[TBL] [Abstract][Full Text] [Related]
4. Increased expression of miR-21 predicts poor prognosis in patients with hepatocellular carcinoma.
Huang CS; Yu W; Cui H; Wang YJ; Zhang L; Han F; Huang T
Int J Clin Exp Pathol; 2015; 8(6):7234-8. PubMed ID: 26261620
[TBL] [Abstract][Full Text] [Related]
5. Downregulation of MAGI1 associates with poor prognosis of hepatocellular carcinoma.
Zhang G; Liu T; Wang Z
J Invest Surg; 2012 Apr; 25(2):93-9. PubMed ID: 21942217
[TBL] [Abstract][Full Text] [Related]
6. MiR-425-5p promotes invasion and metastasis of hepatocellular carcinoma cells through SCAI-mediated dysregulation of multiple signaling pathways.
Fang F; Song T; Zhang T; Cui Y; Zhang G; Xiong Q
Oncotarget; 2017 May; 8(19):31745-31757. PubMed ID: 28423650
[TBL] [Abstract][Full Text] [Related]
7. Expression of serum miR-218 in hepatocellular carcinoma and its prognostic significance.
Yang L; Xu Q; Xie H; Gu G; Jiang J
Clin Transl Oncol; 2016 Aug; 18(8):841-7. PubMed ID: 26586116
[TBL] [Abstract][Full Text] [Related]
8. Methylation-mediated repression of microRNA-129-2 suppresses cell aggressiveness by inhibiting high mobility group box 1 in human hepatocellular carcinoma.
Liu Z; Dou C; Yao B; Xu M; Ding L; Wang Y; Jia Y; Li Q; Zhang H; Tu K; Song T; Liu Q
Oncotarget; 2016 Jun; 7(24):36909-36923. PubMed ID: 27191994
[TBL] [Abstract][Full Text] [Related]
9. Significantly different expression levels of microRNAs associated with vascular invasion in hepatocellular carcinoma and their prognostic significance after surgical resection.
Song SK; Jung WY; Park SK; Chung CW; Park Y
PLoS One; 2019; 14(9):e0216847. PubMed ID: 31513595
[TBL] [Abstract][Full Text] [Related]
10. miR-106b-5p promotes aggressive progression of hepatocellular carcinoma via targeting RUNX3.
Gu H; Gu S; Zhang X; Zhang S; Zhang D; Lin J; Hasengbayi S; Han W
Cancer Med; 2019 Nov; 8(15):6756-6767. PubMed ID: 31503422
[TBL] [Abstract][Full Text] [Related]
11. MicroRNA-188-5p suppresses tumor cell proliferation and metastasis by directly targeting FGF5 in hepatocellular carcinoma.
Fang F; Chang RM; Yu L; Lei X; Xiao S; Yang H; Yang LY
J Hepatol; 2015 Oct; 63(4):874-85. PubMed ID: 25998163
[TBL] [Abstract][Full Text] [Related]
12. Up-regulation of miR-9 expression predicate advanced clinicopathological features and poor prognosis in patients with hepatocellular carcinoma.
Cai L; Cai X
Diagn Pathol; 2014 Dec; 9():1000. PubMed ID: 25552204
[TBL] [Abstract][Full Text] [Related]
13. miR-26a-5p suppresses tumor metastasis by regulating EMT and is associated with prognosis in HCC.
Chang L; Li K; Guo T
Clin Transl Oncol; 2017 Jun; 19(6):695-703. PubMed ID: 27864783
[TBL] [Abstract][Full Text] [Related]
14. Effects of miR-339-5p on invasion and prognosis of hepatocellular carcinoma.
Wang YL; Chen CM; Wang XM; Wang L
Clin Res Hepatol Gastroenterol; 2016 Feb; 40(1):51-6. PubMed ID: 26186881
[TBL] [Abstract][Full Text] [Related]
15. Neuron-glial antigen 2 overexpression in hepatocellular carcinoma predicts poor prognosis.
Lu LL; Sun J; Lai JJ; Jiang Y; Bai LH; Zhang LD
World J Gastroenterol; 2015 Jun; 21(21):6649-59. PubMed ID: 26074703
[TBL] [Abstract][Full Text] [Related]
16. Overexpression of circular RNA circ_001569 indicates poor prognosis in hepatocellular carcinoma and promotes cell growth and metastasis by sponging miR-411-5p and miR-432-5p.
Liu H; Xue L; Song C; Liu F; Jiang T; Yang X
Biochem Biophys Res Commun; 2018 Sep; 503(4):2659-2665. PubMed ID: 30086881
[TBL] [Abstract][Full Text] [Related]
17. Serum miR-182 and miR-331-3p as diagnostic and prognostic markers in patients with hepatocellular carcinoma.
Chen L; Chu F; Cao Y; Shao J; Wang F
Tumour Biol; 2015 Sep; 36(10):7439-47. PubMed ID: 25903466
[TBL] [Abstract][Full Text] [Related]
18. Low-level expression of microRNA-375 predicts poor prognosis in hepatocellular carcinoma.
Zhou N; Wu J; Wang X; Sun Z; Han Q; Zhao L
Tumour Biol; 2016 Feb; 37(2):2145-52. PubMed ID: 26349912
[TBL] [Abstract][Full Text] [Related]
19. High expression of microRNA-130b correlates with poor prognosis of patients with hepatocellular carcinoma.
Wang WY; Zhang HF; Wang L; Ma YP; Gao F; Zhang SJ; Wang LC
Diagn Pathol; 2014 Aug; 9():160. PubMed ID: 25123453
[TBL] [Abstract][Full Text] [Related]
20. Decreased expression of serum miR-424 correlates with poor prognosis of patients with hepatocellular carcinoma.
Yao H; Liu X; Chen S; Xia W; Chen X
Int J Clin Exp Pathol; 2015; 8(11):14830-5. PubMed ID: 26823812
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
